Whalegun
Lobbying

Glaukos GKOS's latest lobbying report covers Q2 2026, at $260K. The four quarters Q4 2025–Q3 2026 total $640K. Its first report covers Q2 2024; the issues it reports most are Medicare/Medicaid and Taxation/Internal Revenue Code.

GlaukosGKOS

Glaukos stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$640K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2024
The first quarter a report named it

Lobbying by quarter

Glaukos lobbying by quarter
Glaukos lobbying by quarter
QuarterAmountReports
Q2 2024$100K2
Q3 2024$110K2
Q4 2024$90K2
Q1 2025$65K2
Q2 2025$70K2
Q3 2025$70K2
Q4 2025$80K2
Q1 2026$300K2
Q2 2026$260K2
Q3 2026$00

By issue

  • Medicare and Medicaid$475K · 17 reports
  • Medical research and clinical labs$370K · 7 reports
  • Taxation$230K · 14 reports
  • Health issues$70K · 9 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
In-houseGlaukos$935K9 quarters
Thorn Run Partners$210K9 quarters

Former officials lobbying for it

Former position
BEAU SCHUYLERLegislative Director: Rep. Tanner; Legislative Director: Rep. McIntyreQ2 2026

Lobbying reports

Filed by
07/19for Q2Thorn Run Partners$20K
07/17for Q2In-house$240K
04/18for Q1Thorn Run Partners$20K
04/10for Q1In-house$280K
01/20for Q4 2025Thorn Run Partners$20K
01/20for Q4 2025In-house$60K
25/10/20for Q3 2025Thorn Run Partners$20K
25/10/20for Q3 2025In-house$50K
25/07/21for Q2 2025In-house$50K
25/07/17for Q2 2025Thorn Run Partners$20K
25/04/17for Q1 2025Thorn Run Partners$20K
25/04/16for Q1 2025In-house$45K
25/01/21for Q4 2024In-house$70K
25/01/19for Q4 2024Thorn Run Partners$20K
24/10/18for Q3 2024Thorn Run Partners$40K
24/10/11for Q3 2024In-house$70K
24/07/19for Q2 2024Thorn Run Partners$30K
24/07/15for Q2 2024In-house$70K
24/05/24for Q2 2024Thorn Run PartnersUnder $5,000
24/04/18for Q2 2024In-houseUnder $5,000